Welcome to LookChem.com Sign In|Join Free

CAS

  • or

196810-82-9

Post Buying Request

196810-82-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

196810-82-9 Usage

Chemical structure

Contains both imidazole and phenyl moieties

Neurotoxin

Linked to Parkinson's disease

Mechanism

Selectively toxic to dopamine-producing neurons in the brain, leading to cell degeneration and Parkinson's symptoms

Research use

Used to induce Parkinson's-like symptoms in animal models and study the disease's underlying mechanisms

Legal status

Highly controlled substance, not used in medical treatments

Check Digit Verification of cas no

The CAS Registry Mumber 196810-82-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,6,8,1 and 0 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 196810-82:
(8*1)+(7*9)+(6*6)+(5*8)+(4*1)+(3*0)+(2*8)+(1*2)=169
169 % 10 = 9
So 196810-82-9 is a valid CAS Registry Number.

196810-82-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(1-methyl-4-phenyl-1H-imidazol-2-yl)ethanol

1.2 Other means of identification

Product number -
Other names 2-(1-Methyl-4-phenyl-1H-imidazol-2-yl)-ethanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:196810-82-9 SDS

196810-82-9Relevant articles and documents

TRIAZOLOPYRIDINONE PDE10 INHIBITORS

-

Page/Page column 45, (2013/06/05)

The present invention is directed to triazolopyridinone compounds which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 10 (PDE10). The present invention also relates to the use of such compounds for treating neurological and psychiatric disorders, such as schizophrenia, psychosis or Huntington's disease, and those associated with striatal hypofunction or basal ganglia dysfunction.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 196810-82-9